(Q80182782)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18074075%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

title

Comparison of interferon beta products and azathioprine in the treatment of relapsing-remitting multiple sclerosis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18074075%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

0 references

1 reference

relapsing-remitting multiple sclerosis

1 reference

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18074075%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

author name string

M Etemadifar

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18074075%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

M Janghorbani

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18074075%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

publication date

14 December 2007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18074075%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18074075%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

volume

254

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18074075%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

issue

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18074075%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

page(s)

1723-1728

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18074075%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s00415-007-0637-1

29 December 2019

exact match

0 references

cites work

Not so benign long-term immunosuppression in multiple sclerosis?

1 reference

12 December 2020

A double blind study on azathioprine efficacy in multiple sclerosis: final report

1 reference

12 December 2020

Azathioprine in treatment of multiple sclerosis. Final results of a 41/2-year controlled study of its effectiveness covering 115 patients

1 reference

12 December 2020

Intramuscular interferon beta-1a for disease progression in relapsing multiple sclerosis. The Multiple Sclerosis Collaborative Research Group (MSCRG)

1 reference

12 December 2020

Interferons in the treatment of multiple sclerosis: do they prevent the progression of the disease?

1 reference

12 December 2020

Randomised double-blind placebo-controlled study of interferon beta-1a in relapsing/remitting multiple sclerosis. PRISMS (Prevention of Relapses and Disability by Interferon beta-1a Subcutaneously in Multiple Sclerosis) Study Group

1 reference

12 December 2020

Therapeutic advances: beta-interferon for multiple sclerosis

1 reference

12 December 2020

Azathioprine and interferon beta-1b treatment in relapsing-remitting multiple sclerosis

1 reference

12 December 2020

Risk of cancer from azathioprine therapy in multiple sclerosis: a case-control study.

1 reference

12 December 2020

Interferon beta-1b is effective in relapsing-remitting multiple sclerosis. I. Clinical results of a multicenter, randomized, double-blind, placebo-controlled trial. The IFNB Multiple Sclerosis Study Group

1 reference

12 December 2020

Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials

1 reference

12 December 2020

1 reference

12 December 2020

Comparison of Betaferon, Avonex, and Rebif in treatment of relapsing-remitting multiple sclerosis

1 reference

12 December 2020

Efficacy of azathioprine on multiple sclerosis new brain lesions evaluated using magnetic resonance imaging

1 reference

12 December 2020

Problems with UK government's risk sharing scheme for assessing drugs for multiple sclerosis

1 reference

12 December 2020

Disease-modifying drugs for multiple sclerosis: a rapid and systematic review

1 reference

12 December 2020

Overview of azathioprine treatment in multiple sclerosis

1 reference

12 December 2020

Interferon-beta-1b slows progression of atrophy in RRMS: Three-year follow-up in NAb- and NAb+ patients

1 reference

12 December 2020

Azathioprine and methotrexate in multiple sclerosis

1 reference

12 December 2020

New treatments and azathioprine in multiple sclerosis

1 reference

12 December 2020

Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS)

1 reference

12 December 2020

Management of patients receiving interferon beta-1b for multiple sclerosis: report of a consensus conference

1 reference

12 December 2020

New diagnostic criteria for multiple sclerosis: guidelines for research protocols

1 reference

12 December 2020

Interferon beta-1b is effective in Japanese RRMS patients: a randomized, multicenter study

1 reference

12 December 2020

Double-blind controlled trial of immunosuppression in the treatment of multiple sclerosis: final report

1 reference

12 December 2020

Incidence of cancer in rheumatoid arthritis and other disorders after immunosuppressive treatment

1 reference

12 December 2020

The efficacy of azathioprine in relapsing-remitting multiple sclerosis

1 reference

12 December 2020

Interferon beta-1b in the treatment of multiple sclerosis: final outcome of the randomized controlled trial. The IFNB Multiple Sclerosis Study Group and The University of British Columbia MS/MRI Analysis Group

1 reference

12 December 2020

Extended observations on MS patients treated with IM interferon-beta1a (Avonex): implications for modern MS trials and therapeutics

1 reference

12 December 2020

Interferons in relapsing remitting multiple sclerosis: a systematic review

1 reference

12 December 2020

Disease modifying therapies in multiple sclerosis: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology and the MS Council for Clinical Practice Guidelines

1 reference

12 December 2020

Effects of dose titration on tolerability and efficacy of interferon beta-1b in people with multiple sclerosis

1 reference

12 December 2020